- Home
- CORT vs VRNS Comparison
CORT vs VRNS Comparison
Compare CORT & VRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- VRNS
- Stock Information
- Founded
- CORT 1998
- VRNS 2004
- Country
- CORT United States
- VRNS United States
- Employees
- CORT N/A
- VRNS N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- VRNS Computer Software: Prepackaged Software
- Sector
- CORT Health Care
- VRNS Technology
- Exchange
- CORT Nasdaq
- VRNS Nasdaq
- Market Cap
- CORT 5.9B
- VRNS 5.6B
- IPO Year
- CORT N/A
- VRNS 2014
- Fundamental
- Price
- CORT $51.40
- VRNS $45.30
- Analyst Decision
- CORT Strong Buy
- VRNS Buy
- Analyst Count
- CORT 4
- VRNS 17
- Target Price
- CORT $75.25
- VRNS $58.88
- AVG Volume (30 Days)
- CORT 908.1K
- VRNS 1.6M
- Earning Date
- CORT 02-13-2025
- VRNS 02-03-2025
- Dividend Yield
- CORT N/A
- VRNS N/A
- EPS Growth
- CORT 57.97
- VRNS N/A
- EPS
- CORT 1.26
- VRNS N/A
- Revenue
- CORT $628,555,000.00
- VRNS $546,535,000.00
- Revenue This Year
- CORT $46.29
- VRNS $14.01
- Revenue Next Year
- CORT $17.09
- VRNS $11.79
- P/E Ratio
- CORT $40.77
- VRNS N/A
- Revenue Growth
- CORT 39.67
- VRNS 12.07
- 52 Week Low
- CORT $20.84
- VRNS $41.13
- 52 Week High
- CORT $62.22
- VRNS $60.58
- Technical
- Relative Strength Index (RSI)
- CORT 37.49
- VRNS 26.56
- Support Level
- CORT $53.51
- VRNS $46.83
- Resistance Level
- CORT $60.90
- VRNS $50.69
- Average True Range (ATR)
- CORT 2.69
- VRNS 1.34
- MACD
- CORT -1.24
- VRNS -0.26
- Stochastic Oscillator
- CORT 11.31
- VRNS 14.50
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
About VRNS Varonis Systems Inc.
Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.